SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
SeaStar Medical Holding (Nasdaq: ICU), a commercial-stage medical device company, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The company's management will engage in a fireside chat on September 11, 2024, at 9:00 a.m. Eastern time. Investors can access the webcast through the Events and Presentations section of SeaStar Medical's website.
The conference, scheduled for September 9-11, 2024, will be held at the Lotte New York Palace Hotel, offering both in-person and virtual attendance options. SeaStar Medical's management team will be available for one-on-one meetings throughout the event. Institutional investors and industry professionals interested in attending can register for either virtual or in-person participation.
SeaStar Medical Holding (Nasdaq: ICU), un'azienda di dispositivi medici in fase commerciale, ha annunciato la sua partecipazione alla 26ª Conferenza Annuale Globale sugli Investimenti di H.C. Wainwright. La direzione dell'azienda parteciperà a una chiacchierata informale il 11 settembre 2024, alle 9:00 ora orientale. Gli investitori possono accedere alla trasmissione in streaming attraverso la sezione Eventi e Presentazioni del sito web di SeaStar Medical.
La conferenza, in programma dal 9 all'11 settembre 2024, si terrà presso il Lotte New York Palace Hotel, offrendo opzioni di partecipazione sia in presenza che virtuali. Il team di gestione di SeaStar Medical sarà disponibile per incontri individuali durante l'evento. Gli investitori istituzionali e i professionisti del settore interessati a partecipare possono registrarsi per la partecipazione virtuale o in presenza.
SeaStar Medical Holding (Nasdaq: ICU), una empresa de dispositivos médicos en etapa comercial, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversiones de H.C. Wainwright. La dirección de la compañía participará en una charla informal el 11 de septiembre de 2024, a las 9:00 a.m. hora del Este. Los inversores pueden acceder a la transmisión en vivo a través de la sección de Eventos y Presentaciones en el sitio web de SeaStar Medical.
La conferencia, programada del 9 al 11 de septiembre de 2024, se llevará a cabo en el Lotte New York Palace Hotel, ofreciendo opciones de asistencia tanto en persona como virtual. El equipo de gestión de SeaStar Medical estará disponible para reuniones individuales durante el evento. Los inversores institucionales y profesionales de la industria interesados en asistir pueden registrarse para participar de manera virtual o en persona.
SeaStar Medical Holding (Nasdaq: ICU)는 상업 단계 의료기기 회사로서 H.C. Wainwright 제26회 연례 글로벌 투자 회의에 참여한다고 발표했습니다. 회사의 경영진은 2024년 9월 11일 오전 9시 동부 표준시에 화상 대화를 진행할 예정입니다. 투자자들은 SeaStar Medical 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 웹캐스트에 접근할 수 있습니다.
이번 회의는 2024년 9월 9일부터 11일까지 개최되며, Lotte New York Palace Hotel에서 대면 및 가상 참석 옵션을 제공합니다. SeaStar Medical의 경영진은 행사 기간 동안 일대일 회의에 참석할 수 있습니다. 참석을 희망하는 기관 투자자와 업계 전문가들은 가상 또는 대면 참여를 위해 등록할 수 있습니다.
SeaStar Medical Holding (Nasdaq: ICU), une entreprise de dispositifs médicaux en phase commerciale, a annoncé sa participation à la 26ème Conférence Annuelle Globale d'Investissement de H.C. Wainwright. La direction de l'entreprise participera à une discussion informelle le 11 septembre 2024 à 9h00, heure de l'Est. Les investisseurs peuvent accéder à la webdiffusion via la section Événements et Présentations du site web de SeaStar Medical.
La conférence, prévue du 9 au 11 septembre 2024, se tiendra au Lotte New York Palace Hotel, offrant des options de participation en personne et virtuellement. L'équipe de direction de SeaStar Medical sera disponible pour des réunions individuelles tout au long de l'événement. Les investisseurs institutionnels et les professionnels du secteur intéressés à participer peuvent s'inscrire pour une participation virtuelle ou en personne.
SeaStar Medical Holding (Nasdaq: ICU), ein Medizintechnikunternehmen in der kommerziellen Phase, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright bekannt gegeben. Das Management des Unternehmens wird am 11. September 2024 um 9:00 Uhr Eastern Time an einem informellen Gespräch teilnehmen. Investoren können die Übertragung über den Bereich Veranstaltungen und Präsentationen auf der Website von SeaStar Medical abrufen.
Die Konferenz, die vom 9. bis 11. September 2024 stattfindet, wird im Lotte New York Palace Hotel abgehalten und bietet sowohl persönliche als auch virtuelle Teilnahmeoptionen an. Das Management-Team von SeaStar Medical steht während der Veranstaltung für Einzelgespräche zur Verfügung. Institutionelle Investoren und Fachleute aus der Branche, die an einer Teilnahme interessiert sind, können sich für die virtuelle oder persönliche Teilnahme registrieren.
- None.
- None.
DENVER, Sept. 05, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11, 2024 at 9:00 a.m. Eastern time. A webcast of the fireside chat will be available on the Events and Presentations section of the Company’s website.
Management is available for in-person and virtual one-on-one meetings throughout the conference being held September 9-11. Institutional investors and industry professionals can register to attend the conference virtually or in-person at the Lotte New York Palace Hotel.
About SeaStar Medical
SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit www.seastarmedical.com or visit us on LinkedIn or X.
Contact:
LHA Investor Relations
Jody Cain
(310) 691-7100
Jcain@lhai.com
# # #
FAQ
When is SeaStar Medical (ICU) participating in the H.C. Wainwright Global Investment Conference?
Where can I watch the webcast of SeaStar Medical's (ICU) fireside chat?
What are the dates for the H.C. Wainwright Global Investment Conference featuring SeaStar Medical (ICU)?
Can investors meet with SeaStar Medical (ICU) management during the conference?
Where is the H.C. Wainwright Global Investment Conference with SeaStar Medical (ICU) taking place?
